JAM
CPRX

Jupiter Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Jupiter Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-274,419
Closed -$6.79M – 564
2026
Q1 		$6.79M Sell
274,419
-115,949
-30% -$2.76M 0.04% 319
2025
Q4 		$9.11M Sell
390,368
-10,723
-3% -$239K 0.07% 226
2025
Q3 		$7.9M Sell
401,091
-116,575
-23% -$2.4M 0.07% 240
2025
Q2 		$11.2M Buy
517,666
+29,079
+6% +$686K 0.09% 222
2025
Q1 		$11.8M Buy
488,587
+6,600
+1% +$149K 0.11% 208
2024
Q4 		$10.1M Sell
481,987
-217,957
-31% -$4.68M 0.1% 226
2024
Q3 		$13.9M Sell
699,944
-41,731
-6% -$774K 0.12% 197
2024
Q2 		$11.5M Sell
741,675
-67,685
-8% -$1.05M 0.11% 194
2024
Q1 		$12.9M Sell
809,360
-34,571
-4% -$521K 0.12% 196
2023
Q4 		$14.2M Sell
843,931
-53,115
-6% -$726K 0.14% 181
2023
Q3 		$10.5M Buy
897,046
+350,184
+64% +$4.68M 0.12% 197
2023
Q2 		$7.34M Sell
546,862
-876,722
-62% -$12.6M 0.08% 243
2023
Q1 		$23.6M Buy
1,423,584
+1,376,339
+2,913% +$22.7M 0.33% 97
2022
Q4 		$878K Buy
47,245
+879
+2% +$13.5K 0.01% 376
2022
Q3 		$595K Buy
46,366
+15,679
+51% +$186K 0.01% 423
2022
Q2 		$215K Buy
+30,687
New +$225K ﹤0.01% 549

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Jupiter Asset Management's CPRX Position: Q2 2026 in Review

Jupiter Asset Management sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 274,419 shares — an estimated $6.79M sold.

Jupiter Asset Management first reported a position in CPRX in Q2 2022 and held it in 16 quarters. The position peaked at $23.6M in Q1 2023. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Jupiter Asset Management reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Jupiter Asset Management sold 274,419 Catalyst Pharmaceutical shares in Q2 2026, an estimated $6.79M.
  • Jupiter Asset Management first reported a position in Catalyst Pharmaceutical in Q2 2022 and held it in 16 quarters.
  • Jupiter Asset Management's Catalyst Pharmaceutical position peaked at $23.6M in Q1 2023.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.